Evaluating Ability of HT-6184 to Reduce Inflammation and Pain After Third Molar Extraction

NCT06241742 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

81

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain

Interventions

DRUG: HT-6184
DRUG: HT-6184 Placebo

Sponsor

Halia Therapeutics, Inc.